Pet NSAIDs Market
1 Pet NSAIDs Market Overview
1.1 Product Overview and Scope of Pet NSAIDs
1.2 Pet NSAIDs Segment by Type
1.2.1 Global Pet NSAIDs Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Carprofen
1.2.3 Deracoxib
1.2.4 Firocoxib
1.2.5 Meloxicam
1.3 Pet NSAIDs Segment by Application
1.3.1 Global Pet NSAIDs Sales Comparison by Application: (2022-2028)
1.3.2 Dog
1.3.3 Cat
1.3.4 Horse
1.3.5 Others
1.4 Global Pet NSAIDs Market Size Estimates and Forecasts
1.4.1 Global Pet NSAIDs Revenue 2017-2028
1.4.2 Global Pet NSAIDs Sales 2017-2028
1.4.3 Pet NSAIDs Market Size by Region: 2017 Versus 2021 Versus 2028
2 Pet NSAIDs Market Competition by Manufacturers
2.1 Global Pet NSAIDs Sales Market Share by Manufacturers (2017-2022)
2.2 Global Pet NSAIDs Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Pet NSAIDs Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Pet NSAIDs Manufacturing Sites, Area Served, Product Type
2.5 Pet NSAIDs Market Competitive Situation and Trends
2.5.1 Pet NSAIDs Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Pet NSAIDs Players Market Share by Revenue
2.5.3 Global Pet NSAIDs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Pet NSAIDs Retrospective Market Scenario by Region
3.1 Global Pet NSAIDs Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Pet NSAIDs Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Pet NSAIDs Market Facts & Figures by Country
3.3.1 North America Pet NSAIDs Sales by Country
3.3.2 North America Pet NSAIDs Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Pet NSAIDs Market Facts & Figures by Country
3.4.1 Europe Pet NSAIDs Sales by Country
3.4.2 Europe Pet NSAIDs Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Pet NSAIDs Market Facts & Figures by Region
3.5.1 Asia Pacific Pet NSAIDs Sales by Region
3.5.2 Asia Pacific Pet NSAIDs Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Pet NSAIDs Market Facts & Figures by Country
3.6.1 Latin America Pet NSAIDs Sales by Country
3.6.2 Latin America Pet NSAIDs Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Pet NSAIDs Market Facts & Figures by Country
3.7.1 Middle East and Africa Pet NSAIDs Sales by Country
3.7.2 Middle East and Africa Pet NSAIDs Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Pet NSAIDs Historic Market Analysis by Type
4.1 Global Pet NSAIDs Sales Market Share by Type (2017-2022)
4.2 Global Pet NSAIDs Revenue Market Share by Type (2017-2022)
4.3 Global Pet NSAIDs Price by Type (2017-2022)
5 Global Pet NSAIDs Historic Market Analysis by Application
5.1 Global Pet NSAIDs Sales Market Share by Application (2017-2022)
5.2 Global Pet NSAIDs Revenue Market Share by Application (2017-2022)
5.3 Global Pet NSAIDs Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Zoetis
6.1.1 Zoetis Corporation Information
6.1.2 Zoetis Description and Business Overview
6.1.3 Zoetis Pet NSAIDs Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Zoetis Pet NSAIDs Product Portfolio
6.1.5 Zoetis Recent Developments/Updates
6.2 Elanco
6.2.1 Elanco Corporation Information
6.2.2 Elanco Description and Business Overview
6.2.3 Elanco Pet NSAIDs Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Elanco Pet NSAIDs Product Portfolio
6.2.5 Elanco Recent Developments/Updates
6.3 PREVICOX
6.3.1 PREVICOX Corporation Information
6.3.2 PREVICOX Description and Business Overview
6.3.3 PREVICOX Pet NSAIDs Sales, Revenue and Gross Margin (2017-2022)
6.3.4 PREVICOX Pet NSAIDs Product Portfolio
6.3.5 PREVICOX Recent Developments/Updates
6.4 Metacam
6.4.1 Metacam Corporation Information
6.4.2 Metacam Description and Business Overview
6.4.3 Metacam Pet NSAIDs Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Metacam Pet NSAIDs Product Portfolio
6.4.5 Metacam Recent Developments/Updates
6.5 Chanelle Pharma
6.5.1 Chanelle Pharma Corporation Information
6.5.2 Chanelle Pharma Description and Business Overview
6.5.3 Chanelle Pharma Pet NSAIDs Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Chanelle Pharma Pet NSAIDs Product Portfolio
6.5.5 Chanelle Pharma Recent Developments/Updates
6.6 AVENTIX
6.6.1 AVENTIX Corporation Information
6.6.2 AVENTIX Description and Business Overview
6.6.3 AVENTIX Pet NSAIDs Sales, Revenue and Gross Margin (2017-2022)
6.6.4 AVENTIX Pet NSAIDs Product Portfolio
6.6.5 AVENTIX Recent Developments/Updates
6.7 Woodruff
6.6.1 Woodruff Corporation Information
6.6.2 Woodruff Description and Business Overview
6.6.3 Woodruff Pet NSAIDs Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Woodruff Pet NSAIDs Product Portfolio
6.7.5 Woodruff Recent Developments/Updates
6.8 KRKA UK Ltd
6.8.1 KRKA UK Ltd Corporation Information
6.8.2 KRKA UK Ltd Description and Business Overview
6.8.3 KRKA UK Ltd Pet NSAIDs Sales, Revenue and Gross Margin (2017-2022)
6.8.4 KRKA UK Ltd Pet NSAIDs Product Portfolio
6.8.5 KRKA UK Ltd Recent Developments/Updates
6.9 Dechra
6.9.1 Dechra Corporation Information
6.9.2 Dechra Description and Business Overview
6.9.3 Dechra Pet NSAIDs Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Dechra Pet NSAIDs Product Portfolio
6.9.5 Dechra Recent Developments/Updates
6.10 Parnell
6.10.1 Parnell Corporation Information
6.10.2 Parnell Description and Business Overview
6.10.3 Parnell Pet NSAIDs Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Parnell Pet NSAIDs Product Portfolio
6.10.5 Parnell Recent Developments/Updates
6.11 VetUK
6.11.1 VetUK Corporation Information
6.11.2 VetUK Pet NSAIDs Description and Business Overview
6.11.3 VetUK Pet NSAIDs Sales, Revenue and Gross Margin (2017-2022)
6.11.4 VetUK Pet NSAIDs Product Portfolio
6.11.5 VetUK Recent Developments/Updates
6.12 Norbrook
6.12.1 Norbrook Corporation Information
6.12.2 Norbrook Pet NSAIDs Description and Business Overview
6.12.3 Norbrook Pet NSAIDs Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Norbrook Pet NSAIDs Product Portfolio
6.12.5 Norbrook Recent Developments/Updates
6.13 Alivira Animal Health
6.13.1 Alivira Animal Health Corporation Information
6.13.2 Alivira Animal Health Pet NSAIDs Description and Business Overview
6.13.3 Alivira Animal Health Pet NSAIDs Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Alivira Animal Health Pet NSAIDs Product Portfolio
6.13.5 Alivira Animal Health Recent Developments/Updates
6.14 Vedco Inc
6.14.1 Vedco Inc Corporation Information
6.14.2 Vedco Inc Pet NSAIDs Description and Business Overview
6.14.3 Vedco Inc Pet NSAIDs Sales, Revenue and Gross Margin (2017-2022)
6.14.4 Vedco Inc Pet NSAIDs Product Portfolio
6.14.5 Vedco Inc Recent Developments/Updates
6.15 Vethical
6.15.1 Vethical Corporation Information
6.15.2 Vethical Pet NSAIDs Description and Business Overview
6.15.3 Vethical Pet NSAIDs Sales, Revenue and Gross Margin (2017-2022)
6.15.4 Vethical Pet NSAIDs Product Portfolio
6.15.5 Vethical Recent Developments/Updates
6.16 Vetoquinol
6.16.1 Vetoquinol Corporation Information
6.16.2 Vetoquinol Pet NSAIDs Description and Business Overview
6.16.3 Vetoquinol Pet NSAIDs Sales, Revenue and Gross Margin (2017-2022)
6.16.4 Vetoquinol Pet NSAIDs Product Portfolio
6.16.5 Vetoquinol Recent Developments/Updates
6.17 Pivetal
6.17.1 Pivetal Corporation Information
6.17.2 Pivetal Pet NSAIDs Description and Business Overview
6.17.3 Pivetal Pet NSAIDs Sales, Revenue and Gross Margin (2017-2022)
6.17.4 Pivetal Pet NSAIDs Product Portfolio
6.17.5 Pivetal Recent Developments/Updates
7 Pet NSAIDs Manufacturing Cost Analysis
7.1 Pet NSAIDs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Pet NSAIDs
7.4 Pet NSAIDs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Pet NSAIDs Distributors List
8.3 Pet NSAIDs Customers
9 Pet NSAIDs Market Dynamics
9.1 Pet NSAIDs Industry Trends
9.2 Pet NSAIDs Market Drivers
9.3 Pet NSAIDs Market Challenges
9.4 Pet NSAIDs Market Restraints
10 Global Market Forecast
10.1 Pet NSAIDs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Pet NSAIDs by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Pet NSAIDs by Type (2023-2028)
10.2 Pet NSAIDs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Pet NSAIDs by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Pet NSAIDs by Application (2023-2028)
10.3 Pet NSAIDs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Pet NSAIDs by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Pet NSAIDs by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Pet NSAIDs Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Pet NSAIDs Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Pet NSAIDs Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Pet NSAIDs Market Competitive Situation by Manufacturers in 2021
Table 5. Global Pet NSAIDs Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Pet NSAIDs Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Pet NSAIDs Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Pet NSAIDs Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Pet NSAIDs Average Price (US$/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Pet NSAIDs Manufacturing Sites and Area Served
Table 11. Manufacturers Pet NSAIDs Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Pet NSAIDs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pet NSAIDs as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Pet NSAIDs Sales by Region (2017-2022) & (K Units)
Table 16. Global Pet NSAIDs Sales Market Share by Region (2017-2022)
Table 17. Global Pet NSAIDs Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Pet NSAIDs Revenue Market Share by Region (2017-2022)
Table 19. North America Pet NSAIDs Sales by Country (2017-2022) & (K Units)
Table 20. North America Pet NSAIDs Sales Market Share by Country (2017-2022)
Table 21. North America Pet NSAIDs Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Pet NSAIDs Revenue Market Share by Country (2017-2022)
Table 23. Europe Pet NSAIDs Sales by Country (2017-2022) & (K Units)
Table 24. Europe Pet NSAIDs Sales Market Share by Country (2017-2022)
Table 25. Europe Pet NSAIDs Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Pet NSAIDs Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Pet NSAIDs Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Pet NSAIDs Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Pet NSAIDs Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Pet NSAIDs Revenue Market Share by Region (2017-2022)
Table 31. Latin America Pet NSAIDs Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Pet NSAIDs Sales Market Share by Country (2017-2022)
Table 33. Latin America Pet NSAIDs Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Pet NSAIDs Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Pet NSAIDs Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Pet NSAIDs Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Pet NSAIDs Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Pet NSAIDs Revenue Market Share by Country (2017-2022)
Table 39. Global Pet NSAIDs Sales by Type (2017-2022) & (K Units)
Table 40. Global Pet NSAIDs Sales Market Share by Type (2017-2022)
Table 41. Global Pet NSAIDs Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Pet NSAIDs Revenue Share by Type (2017-2022)
Table 43. Global Pet NSAIDs Price by Type (2017-2022) & (US$/Unit)
Table 44. Global Pet NSAIDs Sales (K Units) by Application (2017-2022)
Table 45. Global Pet NSAIDs Sales Market Share by Application (2017-2022)
Table 46. Global Pet NSAIDs Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Pet NSAIDs Revenue Share by Application (2017-2022)
Table 48. Global Pet NSAIDs Price by Application (2017-2022) & (US$/Unit)
Table 49. Zoetis Corporation Information
Table 50. Zoetis Description and Business Overview
Table 51. Zoetis Pet NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 52. Zoetis Pet NSAIDs Product
Table 53. Zoetis Recent Developments/Updates
Table 54. Elanco Corporation Information
Table 55. Elanco Description and Business Overview
Table 56. Elanco Pet NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 57. Elanco Pet NSAIDs Product
Table 58. Elanco Recent Developments/Updates
Table 59. PREVICOX Corporation Information
Table 60. PREVICOX Description and Business Overview
Table 61. PREVICOX Pet NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 62. PREVICOX Pet NSAIDs Product
Table 63. PREVICOX Recent Developments/Updates
Table 64. Metacam Corporation Information
Table 65. Metacam Description and Business Overview
Table 66. Metacam Pet NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 67. Metacam Pet NSAIDs Product
Table 68. Metacam Recent Developments/Updates
Table 69. Chanelle Pharma Corporation Information
Table 70. Chanelle Pharma Description and Business Overview
Table 71. Chanelle Pharma Pet NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 72. Chanelle Pharma Pet NSAIDs Product
Table 73. Chanelle Pharma Recent Developments/Updates
Table 74. AVENTIX Corporation Information
Table 75. AVENTIX Description and Business Overview
Table 76. AVENTIX Pet NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 77. AVENTIX Pet NSAIDs Product
Table 78. AVENTIX Recent Developments/Updates
Table 79. Woodruff Corporation Information
Table 80. Woodruff Description and Business Overview
Table 81. Woodruff Pet NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 82. Woodruff Pet NSAIDs Product
Table 83. Woodruff Recent Developments/Updates
Table 84. KRKA UK Ltd Corporation Information
Table 85. KRKA UK Ltd Description and Business Overview
Table 86. KRKA UK Ltd Pet NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 87. KRKA UK Ltd Pet NSAIDs Product
Table 88. KRKA UK Ltd Recent Developments/Updates
Table 89. Dechra Corporation Information
Table 90. Dechra Description and Business Overview
Table 91. Dechra Pet NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 92. Dechra Pet NSAIDs Product
Table 93. Dechra Recent Developments/Updates
Table 94. Parnell Corporation Information
Table 95. Parnell Description and Business Overview
Table 96. Parnell Pet NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 97. Parnell Pet NSAIDs Product
Table 98. Parnell Recent Developments/Updates
Table 99. VetUK Corporation Information
Table 100. VetUK Description and Business Overview
Table 101. VetUK Pet NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 102. VetUK Pet NSAIDs Product
Table 103. VetUK Recent Developments/Updates
Table 104. Norbrook Corporation Information
Table 105. Norbrook Description and Business Overview
Table 106. Norbrook Pet NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 107. Norbrook Pet NSAIDs Product
Table 108. Norbrook Recent Developments/Updates
Table 109. Alivira Animal Health Corporation Information
Table 110. Alivira Animal Health Description and Business Overview
Table 111. Alivira Animal Health Pet NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 112. Alivira Animal Health Pet NSAIDs Product
Table 113. Alivira Animal Health Recent Developments/Updates
Table 114. Vedco Inc Corporation Information
Table 115. Vedco Inc Description and Business Overview
Table 116. Vedco Inc Pet NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 117. Vedco Inc Pet NSAIDs Product
Table 118. Vedco Inc Recent Developments/Updates
Table 119. Vethical Corporation Information
Table 120. Vethical Description and Business Overview
Table 121. Vethical Pet NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 122. Vethical Pet NSAIDs Product
Table 123. Vethical Recent Developments/Updates
Table 124. Vetoquinol Corporation Information
Table 125. Vetoquinol Description and Business Overview
Table 126. Vetoquinol Pet NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 127. Vetoquinol Pet NSAIDs Product
Table 128. Vetoquinol Recent Developments/Updates
Table 129. Pivetal Corporation Information
Table 130. Pivetal Description and Business Overview
Table 131. Pivetal Pet NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 132. Pivetal Pet NSAIDs Product
Table 133. Pivetal Recent Developments/Updates
Table 134. Production Base and Market Concentration Rate of Raw Material
Table 135. Key Suppliers of Raw Materials
Table 136. Pet NSAIDs Distributors List
Table 137. Pet NSAIDs Customers List
Table 138. Pet NSAIDs Market Trends
Table 139. Pet NSAIDs Market Drivers
Table 140. Pet NSAIDs Market Challenges
Table 141. Pet NSAIDs Market Restraints
Table 142. Global Pet NSAIDs Sales Forecast by Type (2023-2028) & (K Units)
Table 143. Global Pet NSAIDs Sales Market Share Forecast by Type (2023-2028)
Table 144. Global Pet NSAIDs Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 145. Global Pet NSAIDs Revenue Market Share Forecast by Type (2023-2028)
Table 146. Global Pet NSAIDs Sales Forecast by Application (2023-2028) & (K Units)
Table 147. Global Pet NSAIDs Sales Market Share Forecast by Application (2023-2028)
Table 148. Global Pet NSAIDs Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 149. Global Pet NSAIDs Revenue Market Share Forecast by Application (2023-2028)
Table 150. Global Pet NSAIDs Sales Forecast by Region (2023-2028) & (K Units)
Table 151. Global Pet NSAIDs Sales Market Share Forecast by Region (2023-2028)
Table 152. Global Pet NSAIDs Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 153. Global Pet NSAIDs Revenue Market Share Forecast by Region (2023-2028)
Table 154. Research Programs/Design for This Report
Table 155. Key Data Information from Secondary Sources
Table 156. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Pet NSAIDs
Figure 2. Global Pet NSAIDs Market Share by Type in 2021 & 2028
Figure 3. Carprofen Product Picture
Figure 4. Deracoxib Product Picture
Figure 5. Firocoxib Product Picture
Figure 6. Meloxicam Product Picture
Figure 7. Global Pet NSAIDs Market Share by Application in 2021 & 2028
Figure 8. Dog
Figure 9. Cat
Figure 10. Horse
Figure 11. Others
Figure 12. Global Pet NSAIDs Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Pet NSAIDs Market Size (2017-2028) & (US$ Million)
Figure 14. Global Pet NSAIDs Sales (2017-2028) & (K Units)
Figure 15. Pet NSAIDs Sales Share by Manufacturers in 2021
Figure 16. Global Pet NSAIDs Revenue Share by Manufacturers in 2021
Figure 17. The Global 5 and 10 Largest Pet NSAIDs Players: Market Share by Revenue in 2021
Figure 18. Pet NSAIDs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 19. Global Pet NSAIDs Sales Market Share by Region (2017-2022)
Figure 20. Global Pet NSAIDs Sales Market Share by Region in 2021
Figure 21. Global Pet NSAIDs Revenue Market Share by Region (2017-2022)
Figure 22. Global Pet NSAIDs Revenue Market Share by Region in 2021
Figure 23. United States Pet NSAIDs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. Canada Pet NSAIDs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. Germany Pet NSAIDs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. France Pet NSAIDs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. U.K. Pet NSAIDs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Italy Pet NSAIDs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. Russia Pet NSAIDs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. China Pet NSAIDs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. Japan Pet NSAIDs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. South Korea Pet NSAIDs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. India Pet NSAIDs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Australia Pet NSAIDs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Taiwan Pet NSAIDs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Indonesia Pet NSAIDs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Thailand Pet NSAIDs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Malaysia Pet NSAIDs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Mexico Pet NSAIDs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Brazil Pet NSAIDs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Argentina Pet NSAIDs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Turkey Pet NSAIDs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Saudi Arabia Pet NSAIDs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. UAE Pet NSAIDs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 45. Sales Market Share of Pet NSAIDs by Type (2017-2022)
Figure 46. Manufacturing Cost Structure of Pet NSAIDs
Figure 47. Manufacturing Process Analysis of Pet NSAIDs
Figure 48. Pet NSAIDs Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
Industry Market Size
